Literature DB >> 30761408

Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.

Kazutoshi Ebisawa1, Yosuke Masamoto1, Junji Tokushige1, Hiroshi Nishi2, Kenjiro Honda2, Munetoshi Hinata3, Kazuhiro Toyama1, Masaomi Nangaku2, Mineo Kurokawa4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30761408     DOI： 10.1007/s00277-019-03616-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.

Authors:  Daichi Fukaya; Tsutomu Inoue; Yuta Kogure; Hiroshi Kajiyama; Keisuke Ishizawa; Takeru Seto; Hajime Hasegawa; Toshihide Mimura; Hirokazu Okada
Journal:  CEN Case Rep       Date:  2020-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.